Click on a filter below to refine your search. Remove a filter to broaden your search.
An increase in annual attributable costs was observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3 to 98.7%.
Patients and caregivers scored higher on AML knowledge and perceived greater efficacy in communicating with oncologists.
Immunocompromised patients still can receive convalescent plasma.
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
Cancer survivors who received chemotherapy are more likely to have fracture; the link were stronger within five years of diagnosis.
These preexisting conditions affect functional impairment, mobility and falls.
A mortality prediction may help guide treatment and advance care planning for community-dwelling older adults with dementia.
A pooled analysis of four large-scale trials demonstrated the sustained effect on colorectal cancer incidence and mortality for 15 years.
Lifelong physical activity or sedentary time, assessed by genotype, may be associated with risk for breast cancer.